Riverpark Capital Management LLC Dexcom Inc Transaction History

Riverpark Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$94.08 - $130.2 $914,175 - $1.27 Million	-9,717 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $438,311 - $549,517	-3,375 Reduced 25.78%	9,717 $5.22 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $274,564 - $368,402	-2,573 Reduced 16.43%	13,092 $7.16 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $25,097 - $31,003	-296 Reduced 1.85%	15,665 $5.63 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $428,844 - $574,541	5,498 Added 52.55%	15,961 $5.9 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $582,133 - $688,430	6,095 Added 139.54%	10,463 $4.31 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $267,643 - $449,801	-4,270 Reduced 49.43%	4,368 $1.77 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $412,810 - $653,291	8,638 New	8,638 $2.33 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Riverpark Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Riverpark Capital Management LLC with notifications on news.